Boston Scientific Corporation (NYSE: BSX) today announced the global launch of its Mustang™ PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The Company plans to launch the product immediately in the U.S., Europe and other international markets.
Boston Scientific developed the Mustang PTA Balloon Catheter to meet physician needs for a low-profile, high-pressure balloon catheter in a wide range of sizes. It is the first to use Boston Scientific's NyBax™ Balloon Material, a proprietary co-extrusion of nylon and Pebax® polymers engineered to provide high-pressure, non-compliant dilatation in a low-profile balloon. The Mustang Balloon Catheter offers excellent rated burst pressure (up to 24 atmospheres) and is the only 7 x 200 mm balloon compatible with a 5 French introducer sheath. Available in 203 sizes, it provides the broadest matrix of any available peripheral balloon.
"The Mustang Balloon Catheter offers a low tip profile and excellent deliverability to accommodate workhorse and complex lesions," said Joe Fitzgerald, Senior Vice President and President of Boston Scientific's Endovascular Unit. "Its versatility and extensive size matrix allow physicians to address nearly every peripheral need, ranging from treating blockages in femoral arteries to dialysis fistulae. The Mustang Balloon Catheter demonstrates Boston Scientific's commitment to continuing its legacy as a pioneer and global leader in peripheral balloon angioplasty."
An estimated 8 to 10 million patients in the United States alone suffer from peripheral artery disease (PAD), which is characterized by blockages in vessels of the peripheral vasculature and is associated with high rates of morbidity. PTA balloon catheters are used in peripheral angioplasty and stenting procedures to open blocked arteries.
Experts recommend shortening the blanking period after atrial fibrillation ablation